🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a national, multi-center, open-label, phase IIIb trial to determin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-24
Trial ID
NCT03096847
Treatments Being Tested
The purpose of this study is to explore risk factors for grade 4 neutropeni...
Status
Completed
Location
Pfizer New York
Start Date
2024-08-19
Trial ID
NCT05709158
This non-interventional observational study evaluates the real-world effect...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-02-20
Trial ID
NCT06830720
Treatments Being Tested
This study is a prospective, single arm, multi-center phase II clinical tri...
Status
Recruiting
Location
The First Affiliated Hospital of Zhejiang University
Start Date
2024-06-11
Trial ID
NCT06611813
Treatments Being Tested
This document outlines an investigator-initiated Phase Ib/II clinical trial...
Status
Recruiting
Location
Nagoya City University
Start Date
2025-10-01
Trial ID
NCT07164976
Treatments Being Tested
The purpose of the study is to determine the diagnostic role of ctDNA when ...
Status
Unknown
Location
Asst Papa Giovanni Xxiii- Bergamo
Start Date
2018-05-22
Trial ID
NCT05814224
Treatments Being Tested
The neoadjuvant system therapy (NAST) can significantly increase the pathol...
Status
Active Not Recruiting
Location
Xijing Hospital
Start Date
2026-01-01
Trial ID
NCT07498400
Treatments Being Tested
This is a low-intervention, randomized, non-comparative, open-label, multic...
Status
Recruiting
Location
Charité Berlin
Start Date
2024-01-17
Trial ID
NCT06207734
The purpose of Part 1 of this study is to evaluate the imaging characterist...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-06-23
Trial ID
NCT07630961
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested